Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Medicines Management Training Information For NHS Doncaster Health Care Professionals Who will find this information useful? Trainee GP’s, locum and newly appointed GP’s Nurse prescribers Prescription clerks Newly appointed Medicines Management Pharmacists and Technicians Anyone who works for Doncaster Clinical Commissioning Group (CCG) or in Primary Care and would like to know more about Medicines Management in Doncaster What knowledge will be gained? Outline of the Medicines Management Team role within the CCG and in supporting general practice Overview of Doncaster and Bassetlaw Area Prescribing Committee (APC) Understanding of the Doncaster Traffic Light System Awareness of the functions of various committees How to access the Medicines Management Website Which local drug formularies are available and how to find them What does the Medicines Management Team do? Provide pharmaceutical advice and support to GP practices both in practice and centrally from the CCG office Work closely with colleagues across secondary and primary care, and other health care professionals to ensure safe and cost effective prescribing, by attending various committees across Doncaster and the Yorkshire area. e.g. Area Prescribing Committee (APC), Medicines Management Group (MMG), Formulary Liaison Group (FLG) , Drugs &Therapeutics Committee (D&TC) Provide written documentation/ web based information / face to face dialogue with Localities and practices in Doncaster to assist the prescribing of medication in line with National and Local guidance. Carry out work in practice in line with current cost efficiency programmes. Facilitate work in practice in response to National safety alerts. Produce monthly newsletters cascading important medicines management related issues to practices and community pharmacies. Controlled Drug monitoring and associated committees / meetings. Author: Karen Jennison Checked by: Ning Wong Authorised by: Gill Bradley Date: March 2017 Review Date: March 2019 Version V2.0 S:\Quality & Safety\Medicines Management\Medicines Management Team Project docs\Active The Medicines Management website Information available on the Medicines Management Website includes: Shared care prescribing protocols and proformas National and Local guidance Local formularies APC meeting minutes Traffic light system for medicines Controlled drugs Newsletters This information can be accessed at:- http://medicinesmanagement.doncasterccg.nhs.uk/ The Doncaster and Bassetlaw Area Prescribing Committee (APC) The Area Prescribing Committee (APC) co-ordinates the development of the Traffic Light System (see below) across the Doncaster and Bassetlaw Health Communities by providing consistent, evidenced based advice to the Clinical Commissioning Group, hospital trusts, primary care contractors and non-medical prescribers on prescribing responsibilities for selected medications. The APC has representation from both primary and secondary care as well as members of the Local Medical Committee (LMC) and Local Pharmaceutical Committee (LPC) Author: Karen Jennison Checked by: Ning Wong Authorised by: Gill Bradley Date: March 2017 Review Date: March 2019 Version V2.0 S:\Quality & Safety\Medicines Management\Medicines Management Team Project docs\Active The Traffic Light System The Traffic Light System (TLS) provides guidance to Doncaster and Bassetlaw prescribers on prescribing responsibilities for selected medications. It aims to provide clear understanding of where clinical and prescribing responsibility rests between specialists and GPs. (Please note the guidance on the Traffic Light System has been agreed with Doncaster & Bassetlaw clinicians, and therefore may not always mirror guidance produced outside of this local area.) Criteria for the inclusion of medicines on these lists, or the moving of medicines between the TLS classifications, will be primarily based on: Evidence base Clinical responsibility Patient safety Ensuring appropriate usage Willingness to provide agreed shared care information and the presence of a shared care protocol Each drug is classified under one of the following categories: Red, Amber, Amber with Guidance, Green, Green with Guidance or Grey. The category it is placed in determines the circumstances in which it is recommended to be prescribed and any guidance/rationale which needs to be taken into consideration. When new guidance/information is released on the drug, it is reviewed and the category it is placed in can be changed dependent on its place in therapy. New drugs and changes in classification will be communicated via the T@blet newsletter No Colour Definition: Please be aware if an item does not appear on the TLS it does not automatically mean that it would be coded as GREEN. Reference to the local formulary guidance should always be adhered to. Red Drugs Definition: Initiation and ongoing prescribing should not be undertaken in primary care (unless as part of a specialist GPwSI service) Amber Drugs Amber with Guidance (Amber-G) Green with Guidance (Green-G) Green Grey Definition: Initiation and continued prescribing should only be undertaken under auspices of an agreed shared care protocol Definition: Drug must be initiated and where relevant titrated to stable dosage by specialist before GPs take over prescribing responsibility. There may be a requirement for monitoring to be undertaken by the GP as defined in relevent Amber G Guidance. Click on the underlined drug in the Drug Name column to display comments Definition: Drugs for which GPs may take full responsibility for initiating and ongoing prescribing however, prescribing guidelines apply. Click on the underlined drug in the Drug Name column to display comments Definition: Drugs for which GPs may take full responsibility for initiating and ongoing prescribing however, they are subject to local formulary guidelines. Drugs in this category with appear in the TLS for 6 months from consideration only. Definition: These medicines are not recommended for initiation or prescribing on an NHS prescription in the Doncaster & Bassetlaw Health Care Communities 1. Evidence available supports that use in this area is inappropriate 2. Insufficient evidence available to support its use in therapy 3.Item withdrawn from market/discontinued 4. Drug to be discussed at Doncaster Formulary Liaison Group/Medicines Management Group or other groups before category agreed. Author: Karen Jennison Checked by: Ning Wong Authorised by: Gill Bradley Date: March 2017 Review Date: March 2019 Version V2.0 S:\Quality & Safety\Medicines Management\Medicines Management Team Project docs\Active Other Committees that have representation from Medicines Management in Primary and Secondary care Doncaster Medicines Management Group (MMG) This is a DCCG internal group which has the following remit: Input into Commissioning decisions Assurance Development The Group discusses and approves documents and pieces of work that affect primary care prescribing and ensures all information is cascaded to the appropriate target audience. The Chair can invite guests along to a meeting when specialist knowledge is required to develop a piece of work. This could be a hospital consultant, a CCG Commissioning Lead, or a colleague from another organisation with expertise in a particular clinical area. Rotherham Doncaster and South Humber Foundation Trust Medicines Management Committee (RDaSH FT) This committee is mainly attended by RDaSH FT representatives but the Doncaster CCG Medicines Management Team attends in the role of Commissioner. The main functions are ensuring there is active dialogue between DCCG and RDaSH FT, and that DCCG receives assurance in respect of medicines management issues. This committee is clinically orientated due to RDaSH FT being a provider organisation. The committee covers a broad range of medicines management issues due to RDaSH FT providing a number of services including mental health, community nursing, specialist nursing and the Hospice. Doncaster and Bassetlaw Formulary Liaison Group (FLG) This committee has representatives from primary and secondary care. The committee reviews the joint formularies used in the Doncaster Health community and updates each section on a rotational basis to include new drugs and establishing their place in therapy. Doncaster Drug Formulary The NHS Doncaster Formulary lists all first line medication that can be prescribed by Doncaster clinicians to ensure safe and economic prescribing. The formulary format has recently been amended through collaborative work with DBTHFT and RDaSH FT to cover both secondary and primary prescribing and is reviewed on a regular basis at the FLG meetings. The formulary is Doncaster-wide, and can be accessed on the medicines management website at, http://medicinesmanagement.doncasterccg.nhs.uk/formulary/ Doncaster and Bassetlaw Teaching Hospital Foundation Trust Drug & Therapeutics Committee Author: Karen Jennison Checked by: Ning Wong Authorised by: Gill Bradley Date: March 2017 Review Date: March 2019 Version V2.0 S:\Quality & Safety\Medicines Management\Medicines Management Team Project docs\Active (DBTHFT D&TC) The Drug & Therapeutics Committee is made up of a selection of members from DBTHFT pharmacy, medical and nursing staff and representative from the Doncaster CCG Medicines Management team. The Doncaster Medicines Management team attends in the role of Commissioner. Their main function is ensuring there is active dialogue between DCCG and DBTHFT, and that DCCG receives assurance in respect of medicines management issues. It has the responsibility for the hosting of the local formulary, the assessment of any new drug requests within DBTHFT , the approval of any policies and procedures which involve any drugs or medication related issue, and the monitoring of the Risk Register with respect to pharmaceutical issues. Controlled Drugs (CD’s) The Controlled Drugs Accountable Officer (CDAO), who is employed by NHS England Area Team has lead responsibility for controlled drugs and responsibility for establishing Local Intelligence Network (LIN) arrangements. To enable the CDAO to successfully implement the Controlled Drugs (Supervision of Management and Use) Regulations 2013, NHS England Area Team has an agreed Memorandum of Understanding (MoU) with the CCG to support the CDAO to deliver their required duties. On behalf of the CDAO the Medicines Management team: Host the CD LIN which shares information about controlled drugs and incidents across organisations and geographical areas and receive quarterly occurrence reports. Host the Schedule Drug Monitoring Group (SDMG) which undertake the monitoring and assurance of all Schedule 2 & 3 drugs prescribed in Doncaster Undertake the review and investigations of all CD incidents reported to the CDAO that have occurred in Doncaster Witness CD Destructions in practices and community pharmacies Cost Efficiency Programmes The MMT develops various cost efficiency programmes in line with National directives. The overall aim is to improve the quality of care the NHS delivers while making efficiency savings, which will be reinvested in front line care. Each year the Medicines Management team develop a programme of initiatives in line with local formulary guidance, which are carried out with the consent of each practice. Each piece of work is covered by a Standard Operating Procedure or a guidance document to ensure consistency of working. Author: Karen Jennison Checked by: Ning Wong Authorised by: Gill Bradley Date: March 2017 Review Date: March 2019 Version V2.0 S:\Quality & Safety\Medicines Management\Medicines Management Team Project docs\Active Quality and Safety The Medicines Management team act on drug safety updates and new prescribing guidelines from the National Institute for Health and care Excellence (NICE), UK Medicines Information (UKMI) and Medicines and Healthcare Products Regulatory Agency (MHRA), by providing practices with the relevant information to ensure patients are receiving safe and effective treatment. The Medicines Management team regularly assist practices to identify patients who may require a timely medication review as a result of a safety alert. Information cascaded to GP Practices Medicines Management Newsletter ‘The T@blet ‘– This is produced monthly after the MMG meeting to inform clinicians of any safety updates, cost efficiency work being carried out by the MMT, or any other information that is considered useful in practice. Community Pharmacy Newsletter ‘The Informer’ – This is produced in conjunction with the T@blet and communicates to all community pharmacies in Doncaster to ensure that all parties are aware of the work being carried out by the MMT. If you wish to be added to the distribution list for any of these bulletins/ newsletters, ask your practice manager. We hope this information has been useful to you – if you have any questions please contact us at:- http://medicinesmanagement.doncasterccg.nhs.uk/contact-us/ Author: Karen Jennison Checked by: Ning Wong Authorised by: Gill Bradley Date: March 2017 Review Date: March 2019 Version V2.0 S:\Quality & Safety\Medicines Management\Medicines Management Team Project docs\Active